Shortage of black fungus drug hits Kerala; 20 patients hospitalised in Kozhikode

Representational Image

Kozhikode: With the black fungus disease increasing at an alarming rate in the state, shortage of the medicine has been affecting the treatment. It is learned that the state government has been struggling to resolve the drug shortage.

So far 44 people were infected with black fungus in Kerala. Among them, 20 are under treatment at Kozhikode medical college. But all patients are not Kozhikode natives.

On Monday, 5 patients infected with black fungus were admitted to Kozhikode medical college. A patient from the COVID ward was shifted to the ENT ward after conforming the fungal infection. Special wards are arranged at the ENT section to accommodate black fungus and COVID patients separately.

As the number of patients touched 20, shortage of black fungus drug became a major issue, reported the medical college authority.

It is learned that the hospital authority has been trying to bring the drug from outside Kerala.

The central government also was helpless to ensure the availability of this medicine as there is a huge demand from Kerala.

Patients who have kidney-related ailments need 6 vials of medicine per day. As the number of patients increased, Kerala is trying to bring 50 vials of the medicine.

As this medicine is not available in any drug stores, the health workers are running here and there in search of the medicine.

A Kasaragod native who returned from Delhi, one from Udayam Charity home and one from Tuticorin and two others from other places were admitted to Kozhikode medical college on Monday.

Liposomal Amphotericin B, the medicine used for treating black fungus patients with kidney ailments is out of stock at the medical college. The medical college authority informed that a special health desk facility should be established if the number of patients goes up.

As other patients are not housed in the ENT ward, there are no issues at present, informed the hospital authority.

Add Comment
Related Topics

Get daily updates from

Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.